Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors
Year: 2017
Type: article
Source: Clinical Cancer Research
Authors: Roz Brant, Alan Sharpe, Tom Liptrot, Jonathan R. Dry, Elizabeth A. Harrington, J. Carl Barrett, Nicky Whalley, Christopher Womack, Paul Smith, Darren R. Hodgson
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2530771314
